Skip to main content
ECHOIQ LIMITED logo

ECHOIQ LIMITED — Investor Relations & Filings

Ticker · EIQ ISIN · AU0000195430 LEI · 984500C02FCE7ADF6A81 ASX Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 520 across all filing types
Latest filing 2022-09-29 Annual Report
Country AU Australia
Listing ASX EIQ

About ECHOIQ LIMITED

https://echoiq.ai/

EchoIQ Limited is a medical technology company specializing in the development of artificial intelligence and machine learning solutions for the healthcare sector. The company focuses on enhancing the diagnosis and risk assessment of structural heart disease through its flagship platform, EchoSolv. This cloud-based clinical decision support tool utilizes proprietary algorithms to analyze echocardiographic measurement data, identifying patients at risk of conditions such as aortic stenosis and heart failure. By comparing individual patient data against established clinical guidelines and extensive cardiovascular datasets, the technology assists clinicians in detecting under-diagnosed or misdiagnosed cardiac conditions. The platform is designed to integrate into existing clinical workflows, aiming to improve diagnostic accuracy, optimize patient management, and support timely intervention in cardiovascular care.

Recent filings

Filing Released Lang Actions
Annual Report to shareholders 69 pages 1.1MB
Annual Report Classification · 100% confidence The document is titled 'CONSOLIDATED FINANCIAL REPORT For the Year Ended 30 June 2022' and contains detailed financial statements such as the Consolidated Statement of Profit or Loss and Other Comprehensive Income, Statement of Financial Position, Statement of Changes in Equity, Statement of Cash Flows, Notes to the Financial Statements, Directors' Report, Auditor's Independence Declaration, and Independent Auditor's Report. It also includes corporate governance information and additional ASX information. The document length is 15,000 characters, indicating a full report rather than a brief announcement. The content covers a full fiscal year ending 30 June 2022, which aligns with an annual report. There is no indication that this is merely an announcement or a certification letter. Therefore, this document fits the definition of an Annual Report (10-K equivalent).
2022-09-29 English
Appendix 4G and Corporate Governance Statement 21 pages 375.6KB
Regulatory Filings Classification · 95% confidence The document is titled 'Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations' and references ASX Listing Rules 4.7.3 and 4.10.3. It is a form used by ASX-listed entities to confirm compliance with corporate governance disclosure requirements. The document includes a detailed checklist of governance principles and recommendations, indicating whether the entity has followed them and where disclosures can be found (e.g., in the corporate governance statement or on the website). It explicitly states that Appendix 4G is not a substitute for the corporate governance statement but serves as a verification tool for compliance with Listing Rule 4.10.3. The document is a regulatory filing required by the ASX to accompany the annual report but does not itself contain the full corporate governance statement or annual report. It is a compliance and disclosure verification form, not a full report or presentation. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance documents that do not fit other categories.
2022-09-29 English
Echo IQ USA President Appointed to Lead US Commercialisation 1
Board/Management Information Classification · 100% confidence The document is a company announcement about the appointment of a new President for the US commercialisation efforts. It focuses on management changes and leadership appointments, with no financial data, report references, or regulatory filings. The content fits the category of Board/Management Information (MANG) as it announces a senior management appointment.
2022-09-12 English
Application for quotation of securities - EIQ 8 pages 29.7KB
Share Issue/Capital Change Classification · 95% confidence The document is an application for quotation of securities on the ASX, detailing the issuance and conversion of options into ordinary fully paid shares. It includes specifics about the number of securities, issue dates, and the nature of the securities being quoted. There is no financial performance data, earnings information, or management discussion. The document is a regulatory announcement related to capital changes, specifically the quotation of new securities following conversion of options. This fits the category of Share Issue/Capital Change (SHA). The document length and content confirm it is not a brief announcement or a report publication notice but a substantive filing about capital changes.
2022-09-08 English
Cleansing Notice 1 page 70.9KB
Capital/Financing Update Classification · 95% confidence The document is a short notice regarding the issuance of shares pursuant to the conversion of performance rights. It references compliance with sections of the Corporations Act 2001 and is titled as a 'S708A Cleansing Notice'. The content is a regulatory announcement about share issuance without disclosure under specific legal provisions. It does not contain financial statements, management discussion, or detailed financial data. The document length is only 1570 characters, indicating it is a brief announcement rather than a full report. Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes.
2022-09-08 English
New Research Presented at Leading Cardiology Conference 2 pages 190.9KB
Regulatory Filings Classification · 95% confidence The document is a press release dated 31 August 2022 from Echo IQ Limited announcing new research presented at a cardiology conference and the achievement of SOC 2 compliance. It highlights the presentation of research findings at the European Society of Cardiology Congress and mentions the company's progress towards FDA clearance. There are no financial statements, detailed financial data, or regulatory filing references. The document is an announcement of research and compliance achievements rather than a formal financial or regulatory report. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings. It is a general corporate announcement about research and compliance milestones, which aligns best with the Regulatory Filings (RNS) category as a fallback for miscellaneous announcements that do not fit other specific categories.
2022-08-30 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.